Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

80363 Opioids & opiate analogs 3/4

Pathology & Lab

Also known as: comprehensive opioid panel, multi-agent synthetic opioid screen

Drug screen, opioids and opiate analogs, three or four agents. Comprehensive opioid analogs screening covering multiple synthetic opioid compounds.

In Plain Language

multiple synthetic pain medicine test

Clinical Context

Used for comprehensive opioid monitoring in pain management and addiction medicine programs.

RVU Information

CPT 80363 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.

Billing & Documentation

Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.

How This Code Compares

This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.

Specialties

ToxicologyPain MedicineLaboratory Medicine

Frequently Asked Questions

What is CPT code 80363?

CPT 80363 (Opioids & opiate analogs 3/4) is a Pathology & Lab code. Drug screen, opioids and opiate analogs, three or four agents. Comprehensive opioid analogs screening covering multiple synthetic opioid compounds.

Who uses CPT code 80363?

CPT 80363 is used by Toxicology, Pain Medicine, Laboratory Medicine. Used for comprehensive opioid monitoring in pain management and addiction medicine programs.

When is CPT 80363 used?

Used for comprehensive opioid monitoring in pain management and addiction medicine programs.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against national data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.